Skip to content

Clinical trials

Phase 1/2 Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 1/2 Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20042
20051
20064
20072
20084
20093
20105
20112
20125
201310
20145
20152
20161
20174
20182
20194
20204
20212
20223
20233
20241
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated12
Recruiting11
Unknown status6
Withdrawn3
Not yet recruiting3
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital4
Hadassah Medical Organization3
National Institute of Allergy and Infectious Diseases (NIAID)3
Oregon Health and Science University3
US Department of Veterans Affairs3
University of California, Los Angeles3
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2
Center for Medicinal Cannabis Research2
National Institute of Neurological Disorders and Stroke (NINDS)2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis86
Multiple Sclerosis, Chronic Progressive15
Autoimmune Diseases9
Multiple Sclerosis, Relapsing-Remitting9
Muscle Spasticity5
Fatigue4
Marijuana Abuse4
Demyelinating Diseases3
Nervous System Diseases3
Alzheimer Disease2

Trials

Showing 26 to 50 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.